SearchUnited States
The spirit of innovation is alive at OraSure and all of its subsidiaries. Our scientists are recognized in both established and emerging fields of research including infectious disease, multiomics, human microbiome and human genomics, to name a few. They create discoveries and innovations that can improve lives, change the world, and shape the future of health and wellness. Here’s a snapshot of the research we’re doing around the globe:7
Microbial Pathogenesis, January 2019
A novel chemical lysis method for maximum release of DNA from difficult-to-lyse bacteriaBMC Microbiology, August 2016
A method for assessing efficiency of bacterial cell disruption and DNA releaseOpen Forum Infectious Diseases, December 2015
Maximum release of DNA from difficult-to-lyse bacteria for nucleic acid testing using a novel chemical lysis reagentPeer J, February 2018
Human anti-HIV IgM detection by the OraQuick ADVANCE Rapid HIV 1/2 Antibody TestPLOS Pathogens, June 2015
Protective mAbs and cross-reactive mAbs raised by immunization with engineered marburg virus GPsScience Direct, April 2014
Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challengesAmerican Society for Microbiology, October 2019
Antibiotics and host-tailored probiotics similarly modulate effects on the developing avian microbiome, mycobiome, and host gene expressionAmerican Journal of Primatology, April 2019
Bacterial community structure and function distinguish gut sites in captive red‐shanked doucs (Pygathrix nemaeus)Scientific reports, March 2019
Nutrient-based diet modifications impact on the gut microbiome of the Javan slow loris (Nycticebus javanicus)PLoS genetics, March 2019
Genetic effects on the commensal microbiota in inflammatory bowel disease patientsMDPI Open Access Journals, January 2019
The effects of glucosamine and chondroitin sulfate on gut microbial composition: A systematic review of evidence from animal and human studiesJournal of Medical Primatology, December 2018
Characterization of Campylobacter jejuni, Campylobacter upsaliensis, and a novel Campylobacter sp. in a captive non‐human primate zoological collectionPubMed, May 2014
Role of Fc in antibody-mediated protection from ricin toxin
